Adams P, Lawson S, Sanigorski A, and Sinclair AJ. "Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression." Lipids 31: S157-S161 (1996)

Boizel R, Behhamou PY, Lardy B, Laporte F, Foulon T, and Halimi S. "Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels." Diabetes Care 23: 1679-1685 (2000)

Campbell B, Badrick T, Flatman R, and Kanowshi D. "Limited clinical ultility of high-senistivity plasma C-reactive protein assays." Ann Clin Biochem39: 85-88 (2002)

Campbell B, Flatman R, Badrick T, and Kanowshi D. "Problems with high-sensitivity C-reactive protein." Clin Chem 49: 201 (2003)

Conquer JA, Tierney MC, Zecevic J, Bettger WJ, and Fisher RH. "Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment." Lipids 35: 1305-1312 (2000)

Danesh J, Wheeler JG, Hirschfield GM, Eiriksdottir G, Remley A, Lowe GD, Pepys MB, and Gudnason J. "C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease." N Engl J Med 350: 1387-1397 (2004)

De Lorgeril M, Renaud S, Mamelle N, Salen P, Martin JL, Monjaud I; Guidollet J, Touboul P, and Delaye J.
"Mediterranean alpha-linolenic acid rich diet in secondary prevention of coronary heart disease." Lancet 343: 1454-1459 (1994)

De Longeril M, Salen P, Martin JL, Monjaud I, Delaye J, and Mamelle N. "Mediterranean diet, traditional risk factors, and the rate of cardiovascular  complications after myocardial infarction: final report of the Lyon Diet Heart Study." Circulation 99: 779-785 (1999)

Deron SJ. C-reactive Protein. Contemporary Books. Chicago, IL (2003)

Feng D, Tracy RP, Lipinska I, Murillo J, McKenna C, and Tofler GH. "Effect of short-term aspirin use on C-reactive protein." J Thromb Thrombolysis 9: 37-41 (2000)

Feldman M, Jialal I, Devaraj S, and Cryer B. "Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay." J Am Coll Cardiol 37:2036-2041 (2001)

Gaziano JM, Hennekens CH, O'Donnell CJ, Breslow JL, and Buring JE. "Fasting triglycerides, high-density lipoproteins and risk of myocardial infarction." Circulation 96: 2520-2525 (1997)

Iso H, Sato S, Falsm AR, Shimamoto T, terao A, Munger RG, Kitamure A, Konishi M, Iida M, and Komachi Y. "Serum fatty acids and fish intake in rual Japanese, urban Japanese, Japanese American and Caucasian American men." Int J Epidemiol 18: 374-381 (1989)

Jeppesen J, Hein HO, Suadicani P, and Gyntelberg F. "Low triglycerides-high high-density lipoprotein cholesterol and risk of ischemic heart disease." Arch Intern Med 161: 361-366 (2001)

Kagawa Y, Nishizawa M, Suzuki M, Miyatake T, Hamamoto T, Goto K, Motonaga E, Izumikawa H, Hirata H, and Ebihara A. "Eicosapolyenoic acid of serum lipids of Japanese islanders with low incidence of cardiovascular diseases." J Nutr Sci Vitaminol 28: 441-453 (1982)

Kluft C and de Maat MPM. "Genetics of C-reactive protein." Arthero Thromb Vasc Biol 23: 1956-1959 (2003)

Kromann N and Green A. "Epidemiological studies in Upernavik district, Greenland." Acta Med Scan 208: 401-406 (1974)

Laidlaw M and Holub BJ. "Effects of supplementation with fish oil-derived n-3 fatty acids and gamma-linolenic acid on circulating plasma lipids and fatty acid profiles in women. "Am J Clin Nutr 77: 37-42 (2003)

Lamarche B, Tchernot A, Mauriege P, Cantin B, Gagenais GR, Lupien PJ, and Despres J-P. "Fasting insulin and apolipoprotein B levels and low-density particle size as risk factors for ischemic heart disease." JAMA 279: 1965-1961 (1998)

Maes M. "Fatty acid composition in major depression: decreased n-3 fractions in cholesterol esters and increased C20:n6/C20:5n3 ratio in cholesterol ester and phospholipids." J Affect Dis 38: 35-46 (1996)

Maes M, Christophe A, Delanghe J, Altamura C, Neels, H, and Meltzer HY. "Lowered omega-3 polyunsaturated fatty acids in serum phospholpids and cholesteryl esters of depressed patients." Pscyhiarty Res 85: 275-291 (1999)

Nakamura T, Azuma A, Kuribayashi T, Sugihara H, Okuda S, and Nakagawa M. "Serum fatty acid levels, dietary style and coronary heart in three neighbouring areas in Japan." Brit J Nutr 89: 267-272 (2003)

Nordvik I, Myhr K-M, Nyland H, and Bjerve KS. "Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients." Acta Neurol Scand 102: 143-149 (2000)

Pedesen HS, Mulvad G, Seidelin KN, Malcom GT, and Doudreau DA. "N-3 fatty acids as a risk marker for haemorrhagic stroke." Lancet 353: 812-813 (1999)

Pirro M, Bergeron J, Dagenais GR, Bernard P-M, Cantin B, Depres J-P, and Lamarche B. "Age and duration of follow-up as modulators of the risk for ischemic heart disase asscoaited with high plasma C-reactive protein levels in men." Arch Int Med 161: 2474-2480 (2001)

Ridker PM. "High-sensitivity C-reactive protein." Circulation 103: 1813-1818 (2001)

Ridker PM, Cushman M, Stampfer MJ, Tracy RP, and Hennekens CH. "Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men." N Engl J Med 336: 973-979 (1996)

Ridker PM, Hennekens CH, Buring JE, and Rifai N. "C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women." New Engl J Med 42: 836-843 (2000)

Ridker PM, Fifai N, Stampfer MJ, and Hennekens CH. "Plasma concentration of interleukin-6 and the risk of future myocardinal infarction among apparently healthy men." Circulation 101: 1767-1772 (2000)

Ridker PM, Rifai N, Pfeffer MA, Sacks FM, Moye LA, Goldman S; Flaker GC, Braunwald E. "Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events ( CARE ) Investigators." Circulation  98: 839-44  (1998)

Rifai N and Ridker PM. "High-senistivity C-reactive protein: a novel and promising marker of coronary heart disease." Clin Chem 47: 403-411 (2001)

Sears B. The Omega Rx Zone. Regan Books. New York, NY (2002)

Stevens LJ and Burgess J. "Omega-3 fatty acids in boys with behavior, learning, and health problems." Physiology Behavior 59: 915-920 (1996)

Stevens LJ, Zentall SS, Deck JL, Abate ML, Watkins BA, Lipp SA, and Burgess JR. "Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder." Am J Clin Nutr 62: 761-768 (1995)

Takeda T, Hoshida S, Nishino M, Tanouchi J, Otsu K, and Hori M. "Relationship between effects of statins, aspirin and angiotensin II modulators on high-sensitive C-reactive protein levels." Atherosclerosis 169:155-188 (2003)

Tall AR. "C-reactive protein reassessed." N Engl J Med 350: 1450-1452 (2004)

Upritchard JE, Sutherland WH, and Mann JI. "Effect of supplementation with tomato juice, vitamin E, and vitamin Con LDL oxidation and products of inflammatory activity in type 2 diabetes." Diabetes Care 23: 733-738 (2000)

Yamada T, Strong JP, Ishii T, Ueno T, Koyama M, Wagayama H, Shimizu A, Sakai T, Malcom GT, and Guzman MA. "Atherosclerosis and omega-3 fatty acids in the populations of a fishing village and a farming village in Japan."
Atherosclerosis 153: 469-481 (2000)

Yeni-Komshian H, Caratoni M, Abbasi F, and Reaven GM. "Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers." Diabetes Care 23: 171-175 (2000)